This benefit underlies all the other ones well cover in more detail below [4, 9, 10]
It is found in the nails, hair and skin.* *Results may vary
Common Side Effects (Both Oral and Injectable): Gastrointestinal Issues: These are the most common side effects for all GLP-1 medications: Nausea: Oral semaglutide (Rybelsus): 11-20% of patients Injectable semaglutide (Wegovy): 44% of patients Injectable tirzepatide (Zepbound): 30-37% of patients Why the difference: Lower bioavailability of oral medication means less systemic exposure, potentially resulting in fewer GI side effects
Many people, particularly women of reproductive age , are now using these medications to manage weight
doi:10.1038/s41580-018-0094-y
Safety depends on baseline health status, medical history, and provider oversight for either route